Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
eat whenever you want
The company launched in November 2024 with a specific mission: provide physician-formulated nutritional support for people using GLP-1 receptor agonist medications for weight management
Retatrutide produced 24.2% average weight loss at 48 weeks through triple receptor agonism (GIP/GLP-1/Glucagon), while Survodutide achieved 14.9-18.7% weight loss at 46 weeks through dual receptor agonism (GLP-1/Glucagon)
Storage after reconstitution Once reconstituted, retatrutide should be stored at 2 to 8 degrees Celsius (35.6 to 46.4 degrees Fahrenheit) in the refrigerator
Even though these products are tailor-made (and proven to work) on GLP-1 consumers, theyre certainly not off limits to those not using GLP-1s
US$ 22.40
US$ 28.21
US$ 29.60
US$ 26.08
US$ 28.33
US$ 27.54
